Influenza Vaccines Market 2018: Global Industry Analysis By Top Key Players (AstraZeneca, CSL, GlaxoSmithKline, Sanofi, Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross) and Forecast Up to 2023

Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The CDC estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. When an immunized worker does catch the flu, they are on average back at work a half day sooner. Vaccine effectiveness in those under two years old and over 65 years old remains unknown due to the low quality of the research. needs update][8][needs update] Vaccinating children may protect those around them.

Global Influenza Vaccines Market 2018 which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the market for Influenza Vaccines Sales would rise at a positive CAGR during the period 2018-2023.

Download PDF Sample Of this Report @ https://www.reporthive.com/enquiry.php?id=1618511&req_type=smpl

The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) recommend yearly vaccination for nearly all people over the age of six months, especially those at high risk. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.

The vaccines are generally safe. Fever occurs in five to ten percent of children vaccinated. Temporary muscle pains or feelings of tiredness may occur as well. In certain years, the vaccine has been linked to an increase in Guillain–Barré syndrome among older people at a rate of about one case per million doses. It should not be given to those with severe allergies to eggs or to previous versions of the vaccine. The vaccines come in both inactive and weakened viral forms. The inactive version should be used for those who are pregnant. They come in forms that are injected into a muscle, sprayed into the nose, or injected into the middle layer of the skin.

Vaccination against influenza began in the 1930s with large scale availability in the United States beginning in 1945. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale price in the developing world is about $5.25 USD per dose as of 2014.In the United States, it costs less than $25 USD as of 2015.

Market Segment by Manufacturers, this report covers:
• AstraZeneca
• CSL
• GlaxoSmithKline
• Sanofi
• Altimmune
• BionVax
• FluGen
• FOLIA BIOTECH
• Genentech
• Green Cross and More....

Market Segment by Type, covers:
• Trivalent Flu Vaccines
• Quadrivalent Flu Vaccines

Market Segment by Applications, can be divided into:
• Adults
• Pediatrics

Click Here for Purchase Full Report with Full TOC @ https://www.reporthive.com/enquiry.php?id=1618511&req_type=purch

If you have any special requirements, please let us know and we will offer you the report as you want.

Research objectives
• To study and analyze the global Influenza Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Influenza Vaccines market by identifying its various subsegments.
• Focuses on the key global Influenza Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Influenza Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market. and More…

Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Vaccines Consumption 2013-2023
2.1.2 Influenza Vaccines Consumption CAGR by Region
2.2 Influenza Vaccines Segment by Type
2.2.1 Trivalent Flu Vaccines
2.2.2 Quadrivalent Flu Vaccines
2.3 Influenza Vaccines Consumption by Type
2.3.1 Global Influenza Vaccines Consumption Market Share by Type (2013-2018)

3 Global Influenza Vaccines by Players
3.1 Global Influenza Vaccines Sales Market Share by Players
3.1.1 Global Influenza Vaccines Sales by Players (2016-2018)
3.1.2 Global Influenza Vaccines Sales Market Share by Players (2016-2018)
3.2 Global Influenza Vaccines Revenue Market Share by Players
TOC Continued….!

Tables And Figures
• Figure Picture of Influenza Vaccines
• Table Product Specifications of Influenza Vaccines
• Figure Influenza Vaccines Report Years Considered
• Figure Market Research Methodology
• Figure Global Influenza Vaccines Consumption Growth Rate 2013-2023 (K Units)
• Figure Global Influenza Vaccines Value Growth Rate 2013-2023 ($ Millions)
• Table Influenza Vaccines Consumption CAGR by Region 2013-2023 ($ Millions) and More….

About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME’s, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.

500, North Michigan Avenue,
Suite 6014
Chicago, IL - 60611
United States

Contact Us
Mike Ross
Marketing Manager
sales@reporthive.com
http://www.reporthive.com
Phone Number: +1-312 604 7084

This release was published on openPR.